关注
Adam Olszewski
Adam Olszewski
Associate Professor, Brown University Alpert Medical School
在 brown.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
18562020
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model
M Li, VO Ona, C Guégan, M Chen, V Jackson-Lewis, LJ Andrews, ...
Science 288 (5464), 335, 2000
8632000
Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database
AJ Olszewski, JJ Castillo
Cancer 119 (3), 629-638, 2013
2292013
Epidemiology and survival outcomes of ocular and mucosal melanomas: A population‐based analysis
KD Bishop, AJ Olszewski
International journal of cancer 134 (12), 2961-2971, 2014
2022014
Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19
MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ...
JAMA oncology 7 (8), 1167-1175, 2021
1752021
Sites of extranodal involvement are prognostic in patients with diffuse large B‐cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology and end …
JJ Castillo, ES Winer, AJ Olszewski
American journal of hematology 89 (3), 310-314, 2014
1722014
Outcomes of patients with double-hit lymphoma who achieve first complete remission
DJ Landsburg, MK Falkiewicz, J Maly, KA Blum, C Howlett, T Feldman, ...
Journal of Clinical Oncology 35 (20), 2260-2267, 2017
1652017
Extranodal diffuse large B cell lymphoma: molecular features, prognosis, and risk of central nervous system recurrence
TA Ollila, AJ Olszewski
Current treatment options in oncology 19, 1-20, 2018
1552018
Overall survival and competing risks of death in patients with W aldenström macroglobulinaemia: an analysis of the S urveillance, E pidemiology and E nd R esults database
JJ Castillo, AJ Olszewski, S Kanan, K Meid, ZR Hunter, SP Treon
British Journal of Haematology 169 (1), 81-89, 2015
1462015
Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study
DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ...
Cancer discovery 10 (10), 1514-1527, 2020
1412020
Survival of patients with neuroendocrine carcinoma of the colon and rectum: a population-based analysis
H Shafqat, S Ali, M Salhab, AJ Olszewski
Diseases of the Colon & Rectum 58 (3), 294-303, 2015
1172015
Treatment selection and outcomes in early-stage classical Hodgkin lymphoma: analysis of the National Cancer Data Base
AJ Olszewski, R Shrestha, JJ Castillo
Journal of Clinical Oncology 33 (6), 625-633, 2015
992015
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers
AM Evens, A Danilov, D Jagadeesh, A Sperling, SH Kim, R Vaca, C Wei, ...
Blood, The Journal of the American Society of Hematology 137 (3), 374-386, 2021
932021
Survival trends in Waldenström macroglobulinemia: an analysis of the Surveillance, Epidemiology and End Results database
JJ Castillo, AJ Olszewski, AM Cronin, ZR Hunter, SP Treon
Blood, The Journal of the American Society of Hematology 123 (25), 3999-4000, 2014
922014
Transfusion dependence, use of hospice services, and quality of end-of-life care in leukemia
TW LeBlanc, PC Egan, AJ Olszewski
Blood, The Journal of the American Society of Hematology 132 (7), 717-726, 2018
882018
Population‐based prognostic factors for survival in patients with Burkitt lymphoma: an analysis from the Surveillance, Epidemiology, and End Results database
JJ Castillo, ES Winer, AJ Olszewski
Cancer 119 (20), 3672-3679, 2013
842013
Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma.
JJ Castillo, T Guerrero‐Garcia, F Baldini, E Tchernonog, G Cartron, ...
British journal of haematology 184 (4), 2019
782019
Antibody response to COVID-19 vaccination in adults with hematologic malignant disease
TA Ollila, S Lu, R Masel, A Zayac, K Paiva, RD Rogers, AJ Olszewski
JAMA oncology 7 (11), 1714-1716, 2021
722021
Adjuvant therapy for resected gallbladder cancer: analysis of the national cancer data base
KC Mantripragada, F Hamid, H Shafqat, AJ Olszewski
Journal of the National Cancer Institute 109 (2), djw202, 2017
712017
Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma
TA Ollila, I Sahin, AJ Olszewski
OncoTargets and therapy, 1085-1094, 2019
692019
系统目前无法执行此操作,请稍后再试。
文章 1–20